Log in | Register

Risk of type 2 diabetes mellitus in patients with acute critical illness: a population-based cohort study

Chin-Wang Hsu| Chin-Sheng Lin| Sy-Jou Chen| Shih-Hua Lin| Cheng-Li Lin| Chia-Hung Kao
Original
Volume 42, Issue 1 / January , 2016

Pages 38 - 45

Abstract

Purpose

This large population-based cohort study evaluated the association between certain critical illnesses and the incidence of newly diagnosed type 2 diabetes mellitus (T2DM) in Taiwan.

Methods

Data were obtained from the Taiwan National Health Insurance Research Database. According to age, sex, and propensity score-matching, a cohort comprising 9528 patients with critical illness, including septicemia, septic shock, acute myocardial infarction (AMI), and stroke, and a control cohort of 9528 patients with no critical illness were identified. Cox proportional-hazard regression and competing-risk regression models were employed to evaluate the risk of developing T2DM.

Findings

With the median follow-up periods (interquartile range) of 3.86 (1.64–6.93) and 5.12 (2.51–8.13) years for the patients in the critical illness and control cohorts, respectively, the risk of developing T2DM in the critical illness cohort was significantly higher than in the control cohort (adjusted hazard ratio, aHR = 1.32; 95 % confidence interval, CI 1.16–1.50). In the multivariate competing-risk regression models, the aHR of T2DM was 1.58 (95 % CI 1.45–1.72) in the critical illness cohort. Moreover, among the patients with these critical illnesses, those with septicemia or septic shock exhibited the highest risk of developing T2DM (aHR = 1.51, 95 % CI 1.37–1.67), followed by AMI compared with the control cohort.

Conclusion

Our results suggest that patients with certain critical illnesses are associated with a high risk of developing T2DM. Clinicians should be aware of this association and intensively screen for T2DM in patients following diagnosis of critical illness.

Keywords

References

  1. Preiser JC, Ichai C, Orban JC, Groeneveld AB (2014) Metabolic response to the stress of critical illness. Br J Anaesth 113:945–954
    • View reference on publisher's website
    • View reference on PubMed
  2. Tamita K, Katayama M, Takagi T, Akasaka T, Yamamuro A, Kaji S, Morioka S, Kihara Y (2007) Impact of newly diagnosed abnormal glucose tolerance on long-term prognosis in patients with acute myocardial infarction. Circ J 71:834–841
    • View reference on publisher's website
    • View reference on PubMed
  3. Gornik I, Vujaklija A, Lukic E, Madzarac G, Gasparovic V (2010) Hyperglycemia in sepsis is a risk factor for development of type II diabetes. J Crit Care 25:263–269
    • View reference on publisher's website
    • View reference on PubMed
  4. Benfield T, Jensen JS, Nordestgaard BG (2007) Influence of diabetes and hyperglycaemia on infectious disease hospitalisation and outcome. Diabetologia 50:549–554
    • View reference on publisher's website
    • View reference on PubMed
  5. Christiansen C, Toft P, Jorgensen HS, Andersen SK, Tonnesen E (2004) Hyperglycaemia and mortality in critically ill patients. A prospective study. Intensive Care Med 30:1685–1688
  6. Antonelli M, Bonten M, Chastre J, Citerio G, Conti G, Curtis JR, De Backer D, Hedenstierna G, Joannidis M, Macrae D, Mancebo J, Maggiore SM, Mebazaa A, Preiser JC, Rocco P, Timsit JF, Wernerman J, Zhang H (2012) Year in review in Intensive Care Medicine 2011. II. Cardiovascular, infections, pneumonia and sepsis, critical care organization and outcome, education, ultrasonography, metabolism and coagulation. Intensive Care Med 38:345–358
  7. Eslami S, Taherzadeh Z, Schultz MJ, Abu-Hanna A (2011) Glucose variability measures and their effect on mortality: a systematic review. Intensive Care Med 37:583–593
  8. Gornik I, Vujaklija A, Lukic E, Madzarac G, Gasparovic V (2010) Hyperglycaemia in critical illness is a risk factor for later development of type II diabetes mellitus. Acta Diabetol 47(Suppl 1):29–33
    • View reference on publisher's website
    • View reference on PubMed
  9. MacIntyre EJ, Majumdar SR, Gamble JM, Minhas-Sandhu JK, Marrie TJ, Eurich DT (2012) Stress hyperglycemia and newly diagnosed diabetes in 2124 patients hospitalized with pneumonia. Am J Med 125(1036):e1017–e1023
  10. Okosieme OE, Peter R, Usman M, Bolusani H, Suruliram P, George L, Evans LM (2008) Can admission and fasting glucose reliably identify undiagnosed diabetes in patients with acute coronary syndrome? Diabetes Care 31:1955–1959
    • View reference on publisher's website
    • View reference on PubMed
  11. Parsons LS (2001) Performing a 1: N case-control match on propensity score. SUGI 29:11
  12. Fine JP, Gray RJ (1999) A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94:496–509
    • View reference on publisher's website
  13. Harris MI, Klein R, Welborn TA, Knuiman MW (1992) Onset of NIDDM occurs at least 4–7 yr before clinical diagnosis. Diabetes Care 15:815–819
    • View reference on publisher's website
    • View reference on PubMed
  14. Ginde AA, Cagliero E, Nathan DM, Camargo CA Jr (2008) Point-of-care glucose and hemoglobin A1c in emergency department patients without known diabetes: implications for opportunistic screening. Acad Emerg Med 15:1241–1247
    • View reference on publisher's website
    • View reference on PubMed
  15. Bartnik M, Malmberg K, Norhammar A, Tenerz A, Ohrvik J, Ryden L (2004) Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction. Eur Heart J 25:1990–1997
    • View reference on publisher's website
    • View reference on PubMed
  16. McAllister DA, Hughes KA, Lone N, Mills NL, Sattar N, McKnight J, Wild SH (2014) Stress hyperglycaemia in hospitalised patients and their 3-year risk of diabetes: a Scottish retrospective cohort study. PLoS Med 11:e1001708
    • View reference on publisher's website
    • View reference on PubMed
  17. Boonen E, Van den Berghe G (2014) Endocrine responses to critical illness: novel insights and therapeutic implications. J Clin Endocrinol Metab 99:1569–1582
    • View reference on publisher's website
    • View reference on PubMed
  18. Van den Berghe G (2002) Neuroendocrine pathobiology of chronic critical illness. Crit Care Clin 18:509–528
    • View reference on publisher's website
    • View reference on PubMed
  19. Langouche L, Van den Berghe G (2006) The dynamic neuroendocrine response to critical illness. Endocrinol Metab Clin N Am 35:777–791
  20. Mehta VK, Hao W, Brooks-Worrell BM, Palmer JP (1994) Low-dose interleukin 1 and tumor necrosis factor individually stimulate insulin release but in combination cause suppression. Eur J Endocrinol 130:208–214
    • View reference on publisher's website
    • View reference on PubMed
  21. Grimble RF (2002) Inflammatory status and insulin resistance. Curr Opin Clin Nutr Metab Care 5:551–559
    • View reference on publisher's website
    • View reference on PubMed
  22. Marik PE, Raghavan M (2004) Stress-hyperglycemia, insulin and immunomodulation in sepsis. Intensive Care Med 30:748–756
  23. Montane J, Cadavez L, Novials A (2014) Stress and the inflammatory process: a major cause of pancreatic cell death in type 2 diabetes. Diabetes Metab Syndr Obes 7:25–34
    • View reference on PubMed

Sign In

Connect with ICM

Top 5 Articles Editors Picks Supplement